Annual Working Capital
$91.66 M
+$59.83 M+188.01%
December 31, 2021
Summary
- As of February 10, 2025, CLBS annual working capital is $91.66 million, with the most recent change of +$59.83 million (+188.01%) on December 31, 2021.
- During the last 3 years, CLBS annual working capital has risen by +$53.17 million (+138.16%).
Performance
CLBS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$70.90 M
-$691.00 K-0.97%
September 1, 2022
Summary
- As of February 10, 2025, CLBS quarterly working capital is $70.90 million, with the most recent change of -$691.00 thousand (-0.97%) on September 1, 2022.
- Over the past year, CLBS quarterly working capital has dropped by -$27.14 million (-27.68%).
Performance
CLBS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CLBS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +188.0% | -27.7% |
| 3 y3 years | +138.2% | +192.2% |
| 5 y5 years | +76.0% | +30.3% |
CLBS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -22.6% | at low |
| 5 y | 5-year | at high | -78.2% | -35.3% | -76.6% |
| alltime | all time | at high | -101.4% | -35.3% | -103.6% |
Caladrius Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $70.90 M(-1.0%) |
| Jun 2022 | - | $71.59 M(-18.6%) |
| Mar 2022 | - | $87.90 M(-4.1%) |
| Dec 2021 | $91.66 M(+188.0%) | $91.66 M(-6.5%) |
| Sep 2021 | - | $98.03 M(-5.9%) |
| Jun 2021 | - | $104.22 M(-4.9%) |
| Mar 2021 | - | $109.59 M(+244.4%) |
| Dec 2020 | $31.82 M(+59.2%) | $31.82 M(-14.2%) |
| Sep 2020 | - | $37.08 M(+11.9%) |
| Jun 2020 | - | $33.15 M(+99.8%) |
| Mar 2020 | - | $16.59 M(-17.1%) |
| Dec 2019 | $20.00 M(-48.0%) | $20.00 M(-17.6%) |
| Sep 2019 | - | $24.27 M(-16.6%) |
| Jun 2019 | - | $29.11 M(-15.7%) |
| Mar 2019 | - | $34.55 M(-10.2%) |
| Dec 2018 | $38.49 M(-26.1%) | $38.49 M(-9.1%) |
| Sep 2018 | - | $42.36 M(-7.4%) |
| Jun 2018 | - | $45.72 M(-1.8%) |
| Mar 2018 | - | $46.57 M(-10.6%) |
| Dec 2017 | $52.08 M(+1402.6%) | $52.08 M(-4.3%) |
| Sep 2017 | - | $54.40 M(-2.6%) |
| Jun 2017 | - | $55.86 M(-4468.9%) |
| Mar 2017 | - | -$1.28 M(-136.9%) |
| Dec 2016 | $3.47 M(-58.0%) | $3.47 M(-69.6%) |
| Sep 2016 | - | $11.41 M(+65.5%) |
| Jun 2016 | - | $6.90 M(-59.8%) |
| Mar 2016 | - | $17.15 M(+107.7%) |
| Dec 2015 | $8.26 M(-58.8%) | $8.26 M(-55.9%) |
| Sep 2015 | - | $18.74 M(-39.8%) |
| Jun 2015 | - | $31.14 M(+169.5%) |
| Mar 2015 | - | $11.56 M(-42.3%) |
| Dec 2014 | $20.04 M(-51.2%) | $20.04 M(-32.2%) |
| Sep 2014 | - | $29.56 M(+2.1%) |
| Jun 2014 | - | $28.94 M(-23.4%) |
| Mar 2014 | - | $37.77 M(-7.9%) |
| Dec 2013 | $41.02 M(+507.0%) | $41.02 M(+298.2%) |
| Sep 2013 | - | $10.30 M(+27.7%) |
| Jun 2013 | - | $8.06 M(+133.9%) |
| Mar 2013 | - | $3.45 M(-49.0%) |
| Dec 2012 | $6.76 M(+212.3%) | $6.76 M(-365.1%) |
| Sep 2012 | - | -$2.55 M(-160.2%) |
| Jun 2012 | - | $4.24 M(-27.5%) |
| Mar 2012 | - | $5.84 M(+169.9%) |
| Dec 2011 | $2.16 M(-84.6%) | $2.16 M(-84.1%) |
| Sep 2011 | - | $13.58 M(+195.6%) |
| Jun 2011 | - | $4.59 M(-51.6%) |
| Mar 2011 | - | $9.49 M(-32.4%) |
| Dec 2010 | $14.04 M | $14.04 M(+82.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $7.69 M(-36.4%) |
| Jun 2010 | - | $12.08 M(+13.3%) |
| Mar 2010 | - | $10.66 M(+62.1%) |
| Dec 2009 | $6.58 M(-1626.6%) | $6.58 M(+77.3%) |
| Sep 2009 | - | $3.71 M(-62.9%) |
| Jun 2009 | - | $10.01 M(-582.7%) |
| Mar 2009 | - | -$2.07 M(+381.6%) |
| Dec 2008 | -$430.70 K(-122.3%) | -$430.70 K(-193.4%) |
| Sep 2008 | - | $461.30 K(+24.3%) |
| Jun 2008 | - | $371.00 K(-49.6%) |
| Mar 2008 | - | $735.60 K(-61.9%) |
| Dec 2007 | $1.93 M(-722.7%) | $1.93 M(-43.0%) |
| Sep 2007 | - | $3.39 M(-818.0%) |
| Jun 2007 | - | -$472.20 K(-164.9%) |
| Mar 2007 | - | $727.20 K(-334.5%) |
| Dec 2006 | -$310.10 K(-75.1%) | -$310.10 K(-136.4%) |
| Sep 2006 | - | $851.10 K(-152.2%) |
| Jun 2006 | - | -$1.63 M(+11.0%) |
| Mar 2006 | - | -$1.47 M(+18.0%) |
| Dec 2005 | -$1.25 M(+0.5%) | -$1.25 M(-32.2%) |
| Sep 2005 | - | -$1.84 M(+14.3%) |
| Jun 2005 | - | -$1.61 M(+16.0%) |
| Mar 2005 | - | -$1.39 M(+11.8%) |
| Dec 2004 | -$1.24 M(+56.1%) | -$1.24 M(+26.8%) |
| Sep 2004 | - | -$976.90 K(-19.3%) |
| Jun 2004 | - | -$1.21 M(+5.8%) |
| Mar 2004 | - | -$1.14 M(+44.1%) |
| Dec 2003 | -$793.70 K(+870.3%) | -$793.70 K(+23.1%) |
| Sep 2003 | - | -$644.70 K(+37.4%) |
| Jun 2003 | - | -$469.20 K(+100.2%) |
| Mar 2003 | - | -$234.40 K(+186.6%) |
| Dec 2002 | -$81.80 K(-107.5%) | -$81.80 K(-126.9%) |
| Sep 2002 | - | $304.60 K(-43.9%) |
| Jun 2002 | - | $543.40 K(-26.5%) |
| Mar 2002 | - | $739.50 K(-31.8%) |
| Dec 2001 | $1.08 M(-47.8%) | $1.08 M(-26.3%) |
| Sep 2001 | - | $1.47 M(+2.7%) |
| Jun 2001 | - | $1.43 M(-17.0%) |
| Mar 2001 | - | $1.73 M(-16.8%) |
| Dec 2000 | $2.08 M(-41.8%) | $2.08 M(-46.2%) |
| Sep 2000 | - | $3.86 M(-16.5%) |
| Jun 2000 | - | $4.62 M(-7.4%) |
| Mar 2000 | - | $4.99 M |
| Dec 1999 | $3.57 M(+678.3%) | - |
| Dec 1998 | $458.90 K(-47.2%) | - |
| Mar 1998 | $869.50 K(-233.3%) | - |
| Mar 1997 | -$652.40 K(+103.7%) | - |
| Mar 1996 | -$320.20 K | - |
FAQ
- What is Caladrius Biosciences annual working capital?
- What is the all time high annual working capital for Caladrius Biosciences?
- What is Caladrius Biosciences annual working capital year-on-year change?
- What is Caladrius Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly working capital year-on-year change?
What is Caladrius Biosciences annual working capital?
The current annual working capital of CLBS is $91.66 M
What is the all time high annual working capital for Caladrius Biosciences?
Caladrius Biosciences all-time high annual working capital is $91.66 M
What is Caladrius Biosciences annual working capital year-on-year change?
Over the past year, CLBS annual working capital has changed by +$59.83 M (+188.01%)
What is Caladrius Biosciences quarterly working capital?
The current quarterly working capital of CLBS is $70.90 M
What is the all time high quarterly working capital for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly working capital is $109.59 M
What is Caladrius Biosciences quarterly working capital year-on-year change?
Over the past year, CLBS quarterly working capital has changed by -$27.14 M (-27.68%)